Kieran Engels is CEO and Co-Founder of Seuss+, a strategy and execution partner supporting biotechnology and pharmaceutical sponsors across clinical development. Her work centers on vendor governance, oversight structures, and execution models within sponsor–vendor ecosystems. She has more than a decade of experience working with clinical-stage organizations across Phase 1 to Phase 3 programs, supporting interactions between sponsors, CROs, and clinical service providers. Kieran is based in Amsterdam and works with teams globally in regulated clinical environments.